Wells Fargo MEI Pharma Inc. [MEIP] Price estimation. Who else is faster?


MEI Pharma Inc. [NASDAQ: MEIP] The stock traded higher by 1.70% or 0.0 point at $0.38 with a heavy trading volume of 498471 shares. The company reported on November 18, 2022 that Kyowa Kirin and MEI Pharma announced topline data from the Phase II MIRAGE study in patients with indolent B-cell non-Hodgkin lymphoma in Japan.


China Can’t Stop US$0.25 Of Stock From Mining The Ultra-Rare Metal

Here’s a tiny company—trading at an unheard-of below 25-cents per share—that is developing one of the largest and highest-quality REE deposits in all of North America…and the Chinese are all about it. Can’t do anything! It’s early stages… and that’s great news for individual investors like you who have the foresight to act decisively on an emerging megatrend that is already being measured in the tens of billions of dollars.

Just click here and the name and trading symbol is yours.

sponsored


– Interim data from a phase II study of jandelisib shows an ORR of 75.4% in Japanese patients with indolent B-cell NHL.

– Publication of results from additional Phase 1 study – now available in the International Journal of Hematology.

It opened the trading session at $0.3733, shares rose to $0.395 and fell to $0.3728, the range in which the stock price traded throughout the day. The daily chart for MEIP shows that the company has registered a loss of -8.20% in the last six months. However, it is still -35.71% lower than its most recent trading low.

If we look at the average trading volume of 750.77K shares, MEIP reached a volume of 498471 in the most recent trading day, which is why market watchdogs consider the stock active.

Here are top equity market gurus MEI Pharma Inc. What are you saying about. [MEIP],

Based on careful and fact-backed analysis by Wall Street experts, the current consensus on the target price for MEIP shares is $5.42 per share. Target prices and analysis on the performance of stocks are usually carefully studied by market experts, and the current Wall Street consensus on MEIP stock is a recommendation at 2.20. This rating represents a strong buy recommendation on a scale of 1 to 5, where 5 means strong sell, 4 represents sell, 3 indicates hold and 2 indicates buy.

Wells Fargo maintained its view on the stock as Equal Weight, with its previous recommendation on March 25, 2022, to MEI Pharma Inc. An estimate has been made for the shares of Rs. While these analysts kept their previous recommendation, Stifel cut their target price to $6. $2. The new Note on Price Target has been issued on March 25, 2022, which MEI Pharma Inc. Represents the official price target for the stock. Previously, there was another drop in target price from $4 to $1, while Jefferies maintained a Hold rating on MEIP stock.

MEI Pharma Inc. The Average True Range (ATR) for the MEIP stock is set at 0.03, with a price to sales ratio of 1.26 for the MEIP stock over the trailing 12-month period. The Price to Book ratio for the previous quarter was 1.37, the Price to Cash per Share for the same quarter was set at 1.01.

Trading Performance Analysis for MEIP Stock

MEI Pharma Inc. [MEIP] Reached the green zone at the end of last week, in a positive trend and with a gain of 6.33. With this latest performance, MEIP shares are up 12.62% over the past four-week period, as well as down -8.20% over the past 6 months — not to mention down -86.03% over the past year of trading.

Overbought and oversold stocks can be easily detected with the Relative Strength Index (RSI), where an RSI result of over 70 will result in overbought, and any rate below 30 will indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for the MEIP stock for the past two-week period is set at 56.66, with the RSI for the last one trading hit at 61.94, and the three-week RSI for MEI Pharma Inc. is set at 52.17. [MEIP], The current moving average for the last 50 days of trade of this stock is 0.3755, while it was recorded at 0.3855 for the last one week of trade and 0.7198 for the last 200 days.

MEI Pharma Inc. [MEIP]: A Deep Dive into Fundamental Analysis

The Operating Margin for any stock indicates how profitable the investment will be, and MEI Pharma Inc. [MEIP] The shares currently has an Operating Margin of -185.48 and Gross Margin at +96.97. MEI Pharma Inc. The Net Margin is currently recorded at -133.80.

The Return on Equity for this stock decreased to -116.14 while the Return on Assets stood at -30.95.

MEI Pharma Inc. Equally intriguing is its liquidity data, with a quick ratio of 6.40 and a current ratio set at 6.40.

MEI Pharma Inc. [MEIP]: Earnings Per Share (EPS) Analysis

The company’s progress can be seen through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting 5-year EPS growth rate for MEIP. When it comes to quoted prices, analysts expect MEI Pharma Inc. The 5-year EPS growth rate for .

MEI Pharma Inc. Analysis of insider ownership. [MEIP]

Institutional investors currently hold approximately $18 million, or 38.10% of MEIP stock, in hand. The top three institutional holders of MEIP stock are: NEA MANAGEMENT COMPANY, LLC with ownership of 8,533,072, which is approximately 0% of the company’s market cap and approximately 0.48% of total institutional ownership; Vanguard Group Inc. holds 7,668,708 shares of stock with an estimated value of $2.94 million in MEIP stock shares; and ANSON FUNDS MANAGEMENT LP, currently owning about 0% of the company’s market capitalization with $1.77M in MEIP stock.

MEI Pharma Inc. is held by institutional investors. MEI Pharma Inc.’s share position increased at the end of November and at the time of the November reporting period, where 28 institutional holders held shares of MEI Pharma Inc. I increased my position. [NASDAQ:MEIP] By approximately 2,297,706 shares. Additionally, 32 investors reduced positions by approximately 2,010,276 shares, while 19 investors maintained positions by 43,498,726 shares. As per the latest SEC report filing, the mentioned changes put the institutional holdings at 47,806,708 shares. There were 13 new institutional investments in MEIP stock for a total of 556,357 shares, while 13 institutional investors sold 816,573 shares during the same period.

Leave a Comment

Your email address will not be published.

Then We Knew It Was on..” – Roman Reigns Shark Tank Keto Gummies Scam Alert? McDonald’s Halloween Buckets Could Be Back How to Watch Spacecraft Collide With Deep Space Asteroid Grand Theft Auto VI footage leaked after the hack Floyd Mayweather Jr boxer knocks out Mikuru Asakura martial artist